An Observational Study of Avastin (Bevacizumab) in Combination With Paclitaxel in First-Line Treatment in Patients With HER2-Negative Metastatic Breast Cancer

NCT01661153 · clinicaltrials.gov ↗
COMPLETED
Status
16
Enrollment
INDUSTRY
Sponsor class

Conditions

Sponsor

Hoffmann-La Roche